ABCL
Price
$3.98
Change
-$0.08 (-1.98%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
1.19B
68 days until earnings call
TELO
Price
$1.18
Change
-$0.02 (-1.67%)
Updated
Sep 3 closing price
Capitalization
38.41M
Interact to see
Advertisement

ABCL vs TELO

Header iconABCL vs TELO Comparison
Open Charts ABCL vs TELOBanner chart's image
AbCellera Biologics
Price$3.98
Change-$0.08 (-1.98%)
Volume$109.28K
Capitalization1.19B
Telomir Pharmaceuticals
Price$1.18
Change-$0.02 (-1.67%)
Volume$817K
Capitalization38.41M
ABCL vs TELO Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. TELO commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and TELO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ABCL: $4.05 vs. TELO: $1.20)
Brand notoriety: ABCL and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 66% vs. TELO: 24%
Market capitalization -- ABCL: $1.19B vs. TELO: $38.41M
ABCL [@Biotechnology] is valued at $1.19B. TELO’s [@Biotechnology] market capitalization is $38.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while TELO’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 4 bearish.
  • TELO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than TELO.

Price Growth

ABCL (@Biotechnology) experienced а -7.32% price change this week, while TELO (@Biotechnology) price change was -19.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.19B) has a higher market cap than TELO($38.4M). ABCL YTD gains are higher at: 38.225 vs. TELO (-70.874). TELO has higher annual earnings (EBITDA): -16.08M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. TELO (754K). ABCL has higher revenues than TELO: ABCL (32.9M) vs TELO (0).
ABCLTELOABCL / TELO
Capitalization1.19B38.4M3,094%
EBITDA-197.92M-16.08M1,231%
Gain YTD38.225-70.874-54%
P/E RatioN/AN/A-
Revenue32.9M0-
Total Cash553M754K73,342%
Total Debt142MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABCLTELO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
65%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GILAX13.910.03
+0.22%
Lord Abbett Fundamental Equity C
RYPDX126.61-0.50
-0.39%
Rydex Consumer Products A
CGJIX72.78-0.55
-0.75%
Calvert US Large Cap Growth Rspnb Idx I
JHACX9.82-0.08
-0.81%
JHancock Multi-Asset Absolute Return C
PLGAX16.17-0.14
-0.86%
Principal LargeCap Growth I A

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-3.11%
CRSP - ABCL
59%
Loosely correlated
+1.60%
RXRX - ABCL
58%
Loosely correlated
-0.85%
ABSI - ABCL
54%
Loosely correlated
-2.09%
BEAM - ABCL
53%
Loosely correlated
-0.31%
NTLA - ABCL
52%
Loosely correlated
+0.40%
More

TELO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TELO has been loosely correlated with TNFA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TELO jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-9.09%
TNFA - TELO
36%
Loosely correlated
-21.33%
MEIP - TELO
36%
Loosely correlated
-0.21%
ABCL - TELO
32%
Poorly correlated
-3.11%
CRSP - TELO
32%
Poorly correlated
+1.60%
ENGN - TELO
29%
Poorly correlated
+3.90%
More